Isolation and identification of Haemophilus ducreyi in a clinical study. 1980

F O Sottnek, and J W Biddle, and S J Kraus, and R E Weaver, and J A Stewart

Seventeen strains of Haemophilus ducreyi were isolated from genital lesions which were negative for syphilis by dark-field examination. Media used for primary isolation at various times during the study were enriched chocolate agar, chocolate agar plus vancomycin (3 microgram/ml), rabbit blood agar plus vancomycin (3 micrograms/ml), fetal bovine serum agar, and fetal bovine serum agar plus vancomycin (3 micrograms/ml). H. ducreyi was isolated on chocolate agar plus vancomycin from 10 of 14 patients found to be positive on one or more media, on rabbit blood agar plus vancomycin from 16 of 17 patients, and on fetal bovine serum agar plus vancomycin from 9 of 11 patients. Sera from six animal species were tested to determine if any would support the growth of H. ducreyi. Horse and rabbit sera supported light growth of some strains. Fetal bovine serum supported good growth of all strains included in the study. Biochemical and physiological tests were done on the 17 isolates, a reference strain of H. ducreyi, and two reference strains of Haemophilus haemoglobinophilus. The results agreed with those reported by Kilian, except that H. ducreyi produced alpha-hemolysis in stabs on rabbit blood agar and was oxidase positive, three strains were urease positive, and CO2 improved the growth of seven strains. All 17 isolates were beta-lactamase positive. The reference strains were beta-lactamase negative.

UI MeSH Term Description Entries
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D002602 Chancroid Acute, localized autoinoculable infectious disease usually acquired through sexual contact. Caused by HAEMOPHILUS DUCREYI, it occurs endemically almost worldwide, especially in tropical and subtropical countries and more commonly in seaports and urban areas than in rural areas.
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D006191 Haemophilus ducreyi A species of HAEMOPHILUS that appears to be the pathogen or causative agent of the sexually transmitted disease, CHANCROID. Bacillus ulceris cancrosi,Coccobacillus ducreyi,Hemophilus ducreyi
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000362 Agar A complex sulfated polymer of galactose units, extracted from Gelidium cartilagineum, Gracilaria confervoides, and related red algae. It is used as a gel in the preparation of solid culture media for microorganisms, as a bulk laxative, in making emulsions, and as a supporting medium for immunodiffusion and immunoelectrophoresis.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014640 Vancomycin Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear. AB-Vancomycin,Diatracin,VANCO-cell,Vanco Azupharma,Vanco-saar,Vancocin,Vancocin HCl,Vancocine,Vancomicina Abbott,Vancomicina Chiesi,Vancomicina Combino Phar,Vancomicina Norman,Vancomycin Hexal,Vancomycin Hydrochloride,Vancomycin Lilly,Vancomycin Phosphate (1:2),Vancomycin Phosphate (1:2), Decahydrate,Vancomycin Sulfate,Vancomycin-ratiopharm,Vancomycine Dakota,Hydrochloride, Vancomycin,Sulfate, Vancomycin

Related Publications

F O Sottnek, and J W Biddle, and S J Kraus, and R E Weaver, and J A Stewart
September 1986, Journal of medical microbiology,
F O Sottnek, and J W Biddle, and S J Kraus, and R E Weaver, and J A Stewart
November 1982, Journal of clinical microbiology,
F O Sottnek, and J W Biddle, and S J Kraus, and R E Weaver, and J A Stewart
May 1982, Journal of medical microbiology,
F O Sottnek, and J W Biddle, and S J Kraus, and R E Weaver, and J A Stewart
March 1981, Antonie van Leeuwenhoek,
F O Sottnek, and J W Biddle, and S J Kraus, and R E Weaver, and J A Stewart
April 1982, Journal of clinical microbiology,
F O Sottnek, and J W Biddle, and S J Kraus, and R E Weaver, and J A Stewart
April 1982, The British journal of venereal diseases,
F O Sottnek, and J W Biddle, and S J Kraus, and R E Weaver, and J A Stewart
August 1982, The British journal of venereal diseases,
F O Sottnek, and J W Biddle, and S J Kraus, and R E Weaver, and J A Stewart
February 2002, Current opinion in infectious diseases,
F O Sottnek, and J W Biddle, and S J Kraus, and R E Weaver, and J A Stewart
August 1991, Lancet (London, England),
F O Sottnek, and J W Biddle, and S J Kraus, and R E Weaver, and J A Stewart
October 2023, Enfermedades infecciosas y microbiologia clinica (English ed.),
Copied contents to your clipboard!